SyncVision Systems, Model: 400-0100.10, PN: 30000485688x, with software version 4.2.x

FDA Device Recall #Z-0885-2022 — Class II — January 19, 2022

Recall Summary

Recall Number Z-0885-2022
Classification Class II — Moderate risk
Date Initiated January 19, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Volcano Corporation
Location Rancho Cordova, CA
Product Type Devices
Quantity 3,216

Product Description

SyncVision Systems, Model: 400-0100.10, PN: 30000485688x, with software version 4.2.x

Reason for Recall

If FFR measurement(s) are made prior to an iFR/FFR co-registration/pullback in the same procedural session, this could result in incorrect iFR/FFR Co-Registration results to be displayed, that may cause users to mistakenly use incorrect measurements, leading to inappropriate patient treatment. Image acquisition and processing system operators manual to be updated to include workflow alternatives.

Distribution Pattern

US: WI, CA, CO, MO, ID, DC, LA, VA, KS, OK, GA, KY, IL, AZ, NY, IN, FL, TX, NC, OH, WA, OR, NM, MT, IA, MI, TN, MN, PA, AL, MA, WV, NV, NH, CT, NE, NJ, HI, AR, UT, MD, SC, MS, AK, DE OUS: JP, SA, GB, DE, PT, SG, PL, ZA, NL, MT, ES, IN, GR, EG, FI, HK, FR, NO, DK, BE, AT, IT, CO, KW, MX, PS, QA, CY, CA, TW, LV, SE, HR, SI, MY, KR, IL, TH, AU, BR, CL, SK, CH, LB, OM, ID, PK, IE, NZ, PR, RO, MM, AR, RS, RU, PA, KE, UZ

Lot / Code Information

All serial numbers, limited to cases when: The SyncVision runs the current supported software version 4.2.x, AND The secondary modality (IntraSight IVUS) runs software version 5.x. Device Identifier (DI): 00845225012434

Other Recalls from Volcano Corporation

Recall # Classification Product Date
Z-0674-2020 Class II Philips Volcano FFR software used in the follow... Nov 7, 2018
Z-0727-2019 Class II Visions PV .035 Digital IVUS Catheter, Catalog ... Oct 17, 2018
Z-0726-2019 Class II Visions PV .035 Digital IVUS Catheter, Catalog ... Oct 17, 2018
Z-1891-2018 Class II Philips Volcano CORE M2 Vascular System, Part #... Mar 22, 2018
Z-0189-2018 Class II Volcano Imaging System s5i REF 807400001; CORE ... Nov 3, 2017

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.